SEARCH

SEARCH BY CITATION

References

  • Ahmed, M.A., Al-Sohaibani, M.O., Al-Mohaya, S.A., Sumer, T., Al-Sheikh, E.H. & Knox-Macaulay, H. (1988) Inherited bleeding disorders in the Eastern Province of Saudi Arabia. Acta Haematologica, 79, 202206.
  • Al-Ahmari, A., Ayas, M., Al-Jefri, A., Al-Mahr, M., Rifai, S. & El-Solh, H. (2004) Allogeneic stem cell transplantation for patients with congenital amegakaryocytic thrombocytopenia (CAT). Bone Marrow Transplantation, 33, 829831.
  • Albrecht, C., McVey, J.H., Elliott, J.I., Sardini, A., Kasza, I., Mumford, A.D., Naoumova, R.P., Tuddenham, E.G., Szabo, K. & Higgins, C.F. (2005) A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome. Blood, 106, 542549.
  • Aldrich, R.A., Steinberg, A.G. & Campbell, D.C. (1954) Pedigree demonstrating a sex-linked recessive condition characterised by draining ears, eczematoid dermatitis and bloody diarrhoea. Pediatrics, 13, 133139.
  • Aledort, L.M. (2004) Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity. Journal of Thrombosis and Haemostasis, 2, 17001708.
  • Almeida, A.M., Khair, K., Hann, I. & Liesner, R. (2003) The use of recombinant factor VIIa in children with inherited platelet function disorders. British Journal of Haematology, 121, 477481.
  • Arai, M., Yamamoto, N., Moroi, M., Akamatsu, N., Fukutake, K. & Tanoue, K. (1995) Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency. British Journal of Haematology, 89, 124130.
  • Awidi, A.S. (1984) Congenital hemorrhagic disorders in Jordan. Thrombosis and Haemostasis, 51, 331333.
  • Awidi, A.S. (1992) Delivery of infants with Glanzmann thrombasthenia and subsequent blood transfusion requirements: a follow-up of 39 patients. American Journal of Hematology, 40, 14.
  • Baldini, M.G. (1972) Nature of the platelet defect in the Wiskott–Aldrich syndrome. Annals of the New York Academy of Sciences, 201, 437444.
  • Balduini, C.L., Iolascon, A. & Savoia, A. (2002) Inherited thrombocytopenias: from genes to therapy. Haematologica, 87, 860880.
  • Balduini, C.L., Cattaneo, M., Fabris, F., Gresele, P., Iolascon, A., Pulcinelli, F.M. & Savoia, A. (2003) Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Haematologica, 88, 582592.
  • Ballmaier, N., Schulze, H., Strauss, G., Cherkaoui, K., Wittner, N., Lynen, S., Wolters, S., Bogenberger, J. & Welte, K. (1997) Thrombopoietin in patients with congenital thrombocytopenia and absent radii: elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin’. Blood, 90, 612619.
  • Ballmaier, M., Germeshausen, M., Schulze, H., Cherkaoui, K., Lang, S., Gaudig, A., Krukemeier, S., Eilers, M., Strauss, G. & Welte, K. (2001) c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood, 97, 139146.
  • Ballmaier, M., Germeshausen, M., Krukemeier, S. & Welte, K. (2003) Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia. Annals of the New York Academy of Sciences, 996, 1725.
  • BCSH (1988) Guidelines on platelet function testing. The British Society for Haematology BCSH Haemostasis and Thrombosis Task Force. Journal of Clinical Pathology, 41, 13221330.
  • BCSH (2003a) Guidelines for the use of platelet transfusions. British Journal of Haematology, 122, 1023.
  • BCSH (2003b) Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. British Journal of Haematology, 120, 574596.
  • Bell, J.A. & Savidge, G.F. (2003) Glanzmann's thrombasthenia proposed optimal management during surgery and delivery. Clinical and Applied Thrombosis and Hemostasis, 9, 167170.
  • Bellucci, S. & Caen, J. (2002) Molecular basis of Glanzmann's thrombasthenia and current strategies in treatment. Blood Reviews, 16, 193202.
  • Bernard, J. & Soulier, J.P. (1948) Sur une nouvelle variete de dystrophie thrombocytaire-hemorragipare congenitale. Semaine des Hopitaux de Paris, 244, 159160.
  • Bettache, N., Gaffet, P., Allegre, N., Maurin, L., Toti, F., Freyssinet, J.M. & Bienvenue, A. (1998) Impaired redistribution of aminophospholipids with distinctive cell shape change during Ca2+-induced activation of platelets from a patient with Scott syndrome. British Journal of Haematology, 101, 5058.
  • Bevers, E.M., Wiedmer, T., Comfurius, P., Shattil, S.J., Weiss, H.J., Zwaal, R.F. & Sims, P.J. (1992) Defective Ca(2+)-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome. Blood, 79, 380388.
  • Bolton-Maggs, P.H., Patterson, D.A., Wensley, R.T. & Tuddenham, E.G. (1995) Definition of the bleeding tendency in factor XI-deficient kindreds – a clinical and laboratory study. Thrombosis and Haemostasis, 73, 194202.
  • Bolton-Maggs, P.H., Perry, D.J., Chalmers, E.A., Parapia, L.A., Wilde, J.T., Williams, M.D., Collins, P.W., Kitchen, S., Dolan, G. & Mumford, A.D. (2004) The rare coagulation disorders – review with guidelines for management from the United Kingdom Haemophilia Centre Doctors’ Organisation. Haemophilia, 10, 593628.
  • Breton-Gorius, J., Favier, R., Guichard, J., Cherif, D., Berger, R., Debili, N., Vainchenker, W. & Douay, L. (1995) A new congenital dysmegakaryopoetic thrombocytopenia (Paris–Trousseau) associated with giant platelet alpha granules and chromosome 11 deletion at 11q23. Blood, 85, 18051814.
  • Buchanan, G.B. & Handin, R.I. (1976) Platelet function in the Chediak–Higashi syndrome. Blood, 47, 941945.
  • Budarf, M.L., Konkle, B.A., Ludlow, L.B., Michaud, D., Li, M., Yamashiro, D.J., McDonald-McGinn, D., Zackai, E.H. & Driscoll, D.A. (1995) Identification of a patient with Bernard–Soulier syndrome and a deletion in the DiGeorge/velo-cardio-facial chromosomal region in 22q11.2. Human Molecular Genetics, 4, 763766.
  • Burns, E.R. & Lawrence, C. (1989) Bleeding time. A guide to its diagnostic and clinical utility. Archives of Pathology and Laboratory Medicine, 113, 12191224.
  • Buyukasik, Y., Karakus, S., Goker, H., Haznedaroglu, I.C., Ozatli, D., Sayinalp, N., Ozcebe, O.I., Dundar, S.V. & Kirazli, S. (2002) Rational use of the PFA-100 device for screening of platelet function disorders and von Willebrand disease. Blood Coagulation and Fibrinolysis, 13, 349353.
  • Caglar, K., Cetinkaya, A., Aytac, S., Gumruk, F. & Gurgey, A. (2003) Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia. Pediatric Hematology and Oncology, 20, 435438.
  • Castaman, G., Yu-Feng, L., Battistin, E. & Rodeghiero, F. (1997) Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. British Journal of Haematology, 96, 458463.
  • Cattaneo, M., Lecchi, A., Randi, A.M., McGregor, J.L. & Mannucci, P.M. (1992) Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood, 80, 27872796.
  • Cattaneo, M., Lecchi, A., Lombardi, R., Gachet, C. & Zighetti, M.L. (2000) Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet ‘primary secretion defect’ are heterozygous for a defect of P2CYC receptors. Arteriosclerosis, Thrombosis and Vascular Biology, 20, E101E106.
  • Cattaneo, M., Zighetti, M.L., Lombardi, R., Martinez, C., Lecchi, A., Conley, P.B., Ware, J. & Ruggeri, Z.M. (2003) Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding. Proceedings of the National Academy of Sciences of the United States of America, 100, 19781983.
  • Chiang, P., Oiso, N., Gautam, R., Suzuki, T., Swank, R.T. & Spritz, R.A. (2003) The Hermansky–Pudlak syndrome 1 (HPS1) and HPS4 proteins are components of 2 complexes, BLOC-3 and BLOC-4, involved in the biogenesis of lysosome-related organelles. Journal of Biological Chemistry, 278, 2033220337.
  • Chuansumrit, A., Sangkapreecha, C. & Hathirat, P. (1999) Successful epistaxis control in a patient with Glanzmann thrombasthenia by increased bolus injection dose of recombinant factor VIIa. Thrombosis and Haemostasis, 82, 1778.
  • Cooper, M.D., Chae, H.P., Lowman, J.T., Krivit, W. & Good, R.A. (1968) Wiskott–Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity. American Journal of Medicine, 44, 499513.
  • Cronberg, S. & Nilsson, I.M. (1968) Investigations in a family with thrombasthenia of moderately severe type with 16 affected members. Scandinavian Journal of Haematology, 5, 1725.
  • Cuthbert, R.J., Watson, H.H., Handa, S.I., Abbott, I. & Ludlam, C.A. (1988) DDAVP shortens the bleeding time in Bernard–Soulier syndrome. Thrombosis Research, 49, 649650.
  • Dachary-Prigent, J., Pasquet, J.M., Fressinaud, E., Toti, F., Freyssinet, J.M. & Nurden, A.T. (1997) Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: a study using physiologic agonists and local anaesthetics. British Journal of Haematology, 99, 959967.
  • Day, H.J. & Holmsen, H. (1972) Platelet adenine nucleotide ‘‘storage pool deficiency“ in thrombocytopenic absent radii syndrome. Journal of the American Medical Association, 221, 10531054.
  • De Paepe, A. & Malfait, F. (2004) Bleeding and bruising in patients with Ehlers–Danlos syndrome and other collagen vascular disorders. British Journal of Haematology, 127, 491500.
  • Defreyn, G., Machin, S.J., Carreras, L.O., Dauden, M.V., Chamone, D.A. & Vermylen, J. (1981) Familial bleeding tendency with partial platelet thromboxane synthetase deficiency: reorientation of cyclic endoperoxide metabolism. British Journal of Haematology, 49, 2941.
  • Derry, J.M., Ochs, H.D. & Francke, U. (1994) Isolation of a novel gene mutated in Wiskott–Aldrich syndrome. Cell, 78, 635644.
  • Derry, J.M., Kerns, J.A., Weinberg, K.I., Ochs, H.D., Volpini, V., Estivill, X., Walker, A.P. & Francke, U. (1995) WASP gene mutations in Wiskott–Aldrich syndrome and X-linked thrombocytopenia. Human Molecular Genetics, 4, 11271135.
  • Detter, J.C., Zhang, Q., Mules, E.H., Novak, E.K., Mishra, V.S., Li, W., McMurtrie, E.B., Tchernev, V.T., Wallace, M.R., Seabra, M.C., Swank, R.T. & Kingsmore, S.F. (2000) Rab geranylgeranyl transferase alpha mutation in the gunmetal mouse reduces Rab prenylation and platelet synthesis. Proceedings of the National Academy of Sciences of the United States of America, 97, 41444149.
  • Di Pietro, S.M. & Dell'Angelica, E.C. (2005) The cell biology of Hermansky–Pudlak syndrome: recent advances. Traffic, 6, 525533.
  • Di Pumpo, M., Noris, P., Pecci, A., Savoia, A., Seri, M., Ceresa, I.F. & Balduini, C.L. (2002) Defective expression of GPIb/IX/V complex in platelets from patients with May–Hegglin anomaly and Sebastian syndrome. Haematologica, 87, 943947.
  • DiMichele, D.M. & Hathaway, W.E. (1990) Use of DDAVP in inherited and acquired platelet dysfunction. American Journal of Hematology, 33, 3945.
  • Drachman, J.G. (2004) Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood, 103, 390398.
  • Drouin, A., Favier, R., Masse, J.M., Debili, N., Schmitt, A., Elbim, C., Guichard, J., Adam, M., Gougerot-Pocidalo, M.A. & Cramer, E.M. (2001) Newly recognized cellular abnormalities in the gray platelet syndrome. Blood, 98, 13821391.
  • Falik-Zaccai, T.C., Anikster, Y., Rivera, C.E., Horne, III, M.K., Schliamser, L., Phornphutkul, C., Attias, D., Hyman, T., White, J.G. & Gahl, W.A. (2001) A new genetic isolate of gray platelet syndrome (GPS): clinical, cellular, and hematologic characteristics. Molecular Genetics and Metabolism, 74, 303313.
  • Favaloro, E.J. (2001) Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations. Haemophilia, 7, 170179.
  • Favier, R., Jondeau, K., Boutard, P., Grossfeld, P., Reinert, P., Jones, C., Bertoni, F. & Cramer, E.M. (2003) Paris–Trousseau syndrome: clinical, hematological, molecular data of ten new cases. Thrombosis and Haemostasis, 90, 893897.
  • Filipovich, A.H., Stone, J.V., Tomany, S.C., Ireland, M., Kollman, C., Pelz, C.J., Casper, J.T., Cowan, M.J., Edwards, J.R., Fasth, A., Gale, R.P., Junker, A., Kamani, N.R., Loechelt, B.J., Pietryga, D.W., Ringden, O., Vowels, M., Hegland, J., Williams, A.V., Klein, J.P., Sobocinski, K.A., Rowlings, P.A. & Horowitz, M.M. (2001) Impact of donor type on outcome of bone marrow transplantation for Wiskott–Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood, 97, 15981603.
  • Flood, V.H., Johnson, F.L., Boshkov, L.K., Thomas, G.A., Nugent, D.J., Bakke, A.C., Nicholson, H.S., Tilford, D., Brown, M.P. & Godder, K.T. (2005) Sustained engraftment post bone marrow transplant despite anti-platelet antibodies in Glanzmann thrombasthenia. Pediatric Blood and Cancer, 45, 971975.
  • Francis, J.L. (2002) Platelet function analyzer (PFA100). In: Platelets (ed. by A.D.Michelson), pp. 325335. Academic Press, San Diego, CA.
  • French, D.L., Fruchtman, S., Mitchell, W.B., Coller, B.S. & Peretz, H. (2004) Evidence for megakaryocyte engraftment following reduced-intensity conditioning. Experimental Hematology, 32, 877880.
  • Freson, K., Devriendt, K., Matthijs, G., Van Hoof, A., De Vos, R., Thys, C., Minner, K., Hoylaerts, M.F., Vermylen, J. & Van Geet, C. (2001) Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. Blood, 98, 8592.
  • Freson, K., Thys, C., Wittevrongel, C., Proesmans, W., Hoylaerts, M.F., Vermylen, J. & Van Geet, C. (2002) Pseudohypoparathyroidism type Ib with disturbed imprinting in the GNAS1 cluster and Gsalpha deficiency in platelets. Human Molecular Genetics, 11, 27412750.
  • Freson, K., Hashimoto, H., Thys, C., Wittevrongel, C., Danloy, S., Morita, Y., Shintani, N., Tomiyama, Y., Vermylen, J., Hoylaerts, M.F., Baba, A. & Van Geet, C. (2004) The pituitary adenylate cyclase-activating polypeptide is a physiological inhibitor of platelet activation. Journal of Clinical Investigation, 113, 905912.
  • Fuse, I., Mito, M., Hattori, A., Higuchi, W., Shibata, A., Ushikubi, F., Okuma, M. & Yahata, K. (1993) Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activation. Blood, 81, 9941000.
  • Fuse, I., Hattori, A., Mito, M., Higuchi, W., Yahata, K., Shibata, A. & Aizawa, Y. (1996) Pathogenetic analysis of five cases with a platelet disorder characterized by the absence of thromboxane A2 (TXA2)-induced platelet aggregation in spite of normal TXA2 binding activity. Thrombosis and Haemostasis, 76, 10801085.
  • George, J.N. & Shattil, S.J. (1991) The clinical importance of acquired abnormalities of platelet function. New England Journal of Medicine, 324, 2739.
  • George, J.N., Caen, J.P. & Nurden, A.T. (1990) Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood, 75, 13831395.
  • Gibson, B.E., Todd, A., Roberts, I., Pamphilon, D., Rodeck, C., Bolton-Maggs, P., Burbin, G., Duguid, J., Boulton, F., Cohen, H., Smith, N., McClelland, D.B., Rowley, M. & Turner, G. (2004) Transfusion guidelines for neonates and older children. British Journal of Haematology, 124, 433453.
  • Ginsberg, M.H., Lightsey, A., Kunicki, T.J., Kaufmann, A., Marguerie, G. & Plow, E.F. (1986) Divalent cation regulation of the surface orientation of platelet membrane glycoprotein IIb. Correlation with fibrinogen binding function and definition of a novel variant of Glanzmann's thrombasthenia. Journal of Clinical Investigation, 78, 11031111.
  • Gissen, P., Johnson, C.A., Morgan, N.V., Stapelbroek, J.M., Forshew, T., Cooper, W.N., McKiernan, P.J., Klomp, L.W., Morris, A.A., Wraith, J.E., McClean, P., Lynch, S.A., Thompson, R.J., Lo, B., Quarrell, O.W., Di Rocco, M., Trembath, R.C., Mandel, H., Wali, S., Karet, F.E., Knisely, A.S., Houwen, R.H., Kelly, D.A. & Maher, E.R. (2004) Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome. Nature Genetics, 36, 400404.
  • Go, R.S. & Johnston, K.L. (2003) Acute myelogenous leukemia in an adult with thrombocytopenia with absent radii syndrome. European Journal of Haematology, 70, 246248.
  • Gordon, N., Thom, J., Cole, C. & Baker, R. (1995) Rapid detection of hereditary and acquired platelet storage pool deficiency by flow cytometry. British Journal of Haematology, 89, 117123.
  • Greenhalgh, K.L., Howell, R.T., Bottani, A., Ancliff, P.J., Brunner, H.G., Verschuuren-Bemelmans, C.C., Vernon, E., Brown, K.W. & Newbury-Ecob, R.A. (2002) Thrombocytopenia-absent radius syndrome: a clinical genetic study. Journal of Medical Genetics, 39, 876881.
  • Grottum, K.A. & Solum, N.O. (1969) Congenital thrombocytopenia with giant platelets: a defect in the platelet membrane. British Journal of Haematology, 16, 277290.
  • Gunay-Aygun, M., Huizing, M. & Gahl, W.A. (2004) Molecular defects that affect platelet dense granules. Seminars in Thrombosis and Hemostasis, 30, 537547.
  • Gwynn, B., Ciclotte, S., Hunter, S., Washburn, L.L., Smith R.S., Andersen S.G., Swank R.T., Dell'Angelica E.C., Bonifacino J.S., Eicher E.M. & Peters, L.L. (2000) Defects in the cappucino (cno) gene on mouse chromosome 5 and human 4p cause Hermansky = Pudlak syndrome by and AP-3 independent mechanism. Blood, 96, 42274235.
  • Harrison, P., Ault, K.A., Chapman, S., Charie, L., Davis, B., Fujimoto, K., Houwen, B., Kunicka, J., Lacombe, F., Machin, S., Raynor, R., Van Hove, L. & Van Assendelft, O.W. (2001) An interlaboratory study of a candidate reference method for platelet counting. American Journal of Clinical Pathology, 115, 448459.
  • Harrison, P., Robinson, M., Liesner, R., Khair, K., Cohen, H., Mackie, I. & Machin, S. (2002a) The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction. Clinical and Laboratory Haematology, 24, 225232.
  • Harrison, C., Khair, K., Baxter, B., Russell-Eggitt, I., Hann, I. & Liesner, R. (2002b) Hermansky-Pudlak syndrome: infrequent bleeding and first report of Turkish and Pakastani Kindreds. Archives of Diseases in Childhood, 86, 297301.
  • Hassan, A.A. & Kroll, M.H. (2005) Acquired disorders of platelet function. In: American Society of Hematology Education Program Book (ed. by N.Berliner, S.J.Lee, M.Lineberger & G.B.Vogelsang), pp. 403408. ASH, Berkeley, CA.
  • Hayward, C.P. (1997) Inherited disorders of platelets alpha granules. Platelets, 8, 197209.
  • Hayward, C.P., Rivard, G.E., Kane, W.H., Drouin, J., Zheng, S., Moore, J.C. & Kelton, J.G. (1996) An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect. Blood, 87, 49674978.
  • Hayward, C.P., Cramer, E.M., Kane, W.H., Zheng, S., Bouchard, M., Masse, J.M. & Rivard, G.E. (1997) Studies of a second family with the Quebec platelet disorder: evidence that the degradation of the alpha-granule membrane and its soluble contents are not secondary to a defect in targeting proteins to alpha-granules. Blood, 89, 12431253.
  • Hedberg, V.A. & Lipton, J.M. (1988) Thrombocytopenia with absent radii. A review of 100 cases. American Journal of Pediatric Hematology and Oncology, 10, 5164.
  • Hermansky, F. & Pudlak, P. (1959) Albinism associated with haemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies. Blood, 14, 162169.
  • Higgs, H.N. & Pollard, T.D. (2000) Activation by Cdc42 and PIP(2) of Wiskott–Aldrich syndrome protein (WASp) stimulates actin nucleation by Arp2/3 complex. Journal of Cell Biology, 150, 13111320.
  • Horellou, M.H., Lecompte, T., Lecrubier, C., Fouque, F., Chignard, M., Conard, J., Vargaftig, B.B., Dray, F. & Samama, M. (1983) Familial and constitutional bleeding disorder due to platelet cyclo-oxygenase deficiency. American Journal of Hematology, 14, 19.
  • Huang, L., Kuo, Y.M. & Gitschier, J. (1999) The pallid gene encodes a novel, syntaxin 13-interacting protein involved in platelet storage pool deficiency. Nature Genetics, 23, 329332.
  • Hughan, S.C., Senis, Y., Best, D., Thomas, A., Frampton, J., Vyas, P. & Watson, S.P. (2005) Selective impairment of platelet activation to collagen in the absence of GATA1. Blood, 105, 43694376.
  • Huizing, M., Anikster, Y. & Gahl, W.A. (2001) Hermansky–Pudlak syndrome and Chediak–Higashi syndrome: disorders of vesicle formation and trafficking. Thrombosis and Haemostasis, 86, 233245.
  • Hunter, N., Foster, J., Chong, A., McCutcheon, S., Parnham, D., Eaton, S., MacKenzie, C. & Houston, F. (2002) Transmission of prion diseases by blood transfusion. Journal of General Virology, 83, 28972905.
  • Introne, W., Boissy, R.E. & Gahl, W.A. (1999) Clinical, molecular and cell biological aspects of Chediak–Higashi syndrome. Molecular Genetics and Metabolism, 68, 283303.
  • Ironside, J.W. & Head, M.W. (2004) Variant Creutzfeldt–Jakob disease: risk of transmission by blood and blood products. Haemophilia, 10(Suppl. 4), 6469.
  • Israels, S.J., McNicol, A., Robertson, C. & Gerrard, J.M. (1990) Platelet storage pool deficiency: diagnosis in patients with prolonged bleeding times and normal platelet aggregation. British Journal of Haematology, 75, 118121.
  • Jantunen, E., Hanninen, A., Naukkarinen, A., Vornanen, M. & Lahtinen, R. (1994) Gray platelet syndrome with splenomegaly and signs of extramedullary haematopoesis: a case report with review of the literature. American Journal of Hematology, 46, 218224.
  • Jennings, L.K., Ashmun, R.A., Wang, W.C. & Dockter, M.E. (1986) Analysis of human platelet glycoproteins IIb-IIIa and Glanzmann's thrombasthenia in whole blood by flow cytometry. Blood, 68, 173179.
  • Jilma, B. (2001) Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. Journal of Laboratory and Clinical Medicine, 138, 152163.
  • Jin, Y., Mazza, C., Chrisite, J.R., Giliani, S., Fiorini, M., Mella, P., Gandellini, F., Stewart, D.M., Zhu, Q., Nelson, D.L., Notarangelo, L.D. & Ochs, H.D. (2004) Mutations of the Wiskott–Aldrich syndrome protein (WASP): hot spots, effect on transcription and translation and phenotype/genotype correlation. Blood, 104, 40104019.
  • Kahr, W.H., Zheng, S., Sheth, P.M., Pai, M., Cowie, A., Bouchard, M., Podor, T.J., Rivard, G.E. & Hayward, C.P. (2001) Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. Blood, 98, 257265.
  • Kaleelrahman, M., Minford, A. & Parapia, L.A. (2004) Use of recombinant factor VIIa in inherited platelet disorders. British Journal of Haematology, 125, 9596.
  • Kaufmann, J.E. & Vischer, U.M. (2003) Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). Journal of Thrombosis and Haemostasis, 1, 682689.
  • Kaushansky, K. (2005) The molecular mechanisms that control thrombopoiesis. Journal of Clinical Investigation, 115, 33393347.
  • Kenney, D.M. (1990) Wiskott–Aldrich syndrome and related X-linked thrombocytopenia. Current Opinion in Pediatrics, 2, 931.
  • Kentro, T.B., Lottenberg, R. & Kitchens, C.S. (1987) Clinical efficacy of desmopressin acetate for hemostatic control in patients with primary platelet disorders undergoing surgery. American Journal of Hematology, 24, 215219.
  • Khanduri, U., Pulimood, R., Sudarsanam, A., Carman, R.H., Jadhav, M. & Pereira, S. (1981) Glanzmann's thrombasthenia. A review and report of 42 cases from South India. Thrombosis and Haemostasis, 46, 717721.
  • Kimura, S., Roberts, A.W., Metcalf, D. & Alexander, W.S. (1998) Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proceedings of the National Academy of Sciences of the United States of America, 95, 11951200.
  • Klofkorn, R.W. & Lightsey, A.L. (1979) Hemarthrosis associated with Glanzmann's thrombasthenia. Arthritis and Rheumatism, 22, 13901393.
  • Kohler, M., Hellstern, P., Morgenstern, E., Mueller-Eckhardt, C., Berberich, R., Meiser, R.J., Scheffler, P. & Wenzel, E. (1985) Gray platelet syndrome: selective alpha-granule deficiency and thrombocytopenia due to increased platelet turnover. Blut, 50, 331340.
  • Kojima, H., Newton-Nash, D., Weiss, H.J., Zhao, J., Sims, P.J. & Wiedmer, T. (1994) Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. Journal of Clinical Investigation, 94, 22372244.
  • Kosch, A., Kehrel, B., Nowak-Gottl, U., Haberle, J. & Jurgens, H. (1999) Thrombocytic alpha-delta-storage-pool-disease: shortening of bleeding time after infusion of 1-desamino-8-d-arginine vasopressin. Klinische Padiatrie, 211, 198200.
  • Kwan, S.P., Hagemann, T.L., Radtke, B.E., Blaese, R.M. & Rosen, F.S. (1995) Identification of mutations in the Wiskott–Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene. Proceedings of the National Academy of Sciences of the United States of America, 92, 47064710.
  • Lackner, A., Basu, O., Bierings, M., Lassay, L., Schaefer, U.W., Revesz, T., Havers, W. & Kremens, B. (2000) Haematopoietic stem cell transplantation for amegakaryocytic thrombocytopenia. British Journal of Haematology, 109, 773775.
  • Laffan, M., Brown, S.A., Collins, P.W., Cumming, A.M., Hill, F.G., Keeling, D., Peake, I.R. & Pasi, K.J. (2004) The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors’ Organization. Haemophilia, 10, 199217.
  • Lagarde, M., Byron, P.A., Vargaftig, B.B. & Dechavanne, M. (1978) Impairment of platelet thromboxane A2 generation and of the platelet release reaction in two patients with congenital deficiency of platelet cyclo-oxygenase. British Journal of Haematology, 38, 251266.
  • Lages, B., Malmsten, C., Weiss, H.J. & Samuelsson, B. (1981) Impaired platelet response to thromboxane-A2 and defective calcium mobilization in a patient with a bleeding disorder. Blood, 57, 545552.
  • Lascone, M.R., Sacchelli, M., Vittorini, S. & Giusti, S. (2001) Complex conotruncal heart defect, severe bleeding disorder and 22q11 deletion: a new case of Bernard-Soulier syndrome and of 22q11 deletion syndrome? Italian Heart Journal, 2, 475477.
  • Li, W., Zhang, Q., Oiso, N., Novak, E.K., Gautam, R., O'Brien, E.P., Tinsley, C.L., Blake, D.J., Spritz, R.A., Copeland, N.G., Jenkins, N.A., Amato, D., Roe, B.A., Starcevic, M., Dell'Angelica, E.C., Elliott, R.W., Mishra, V., Kingsmore, S.F., Paylor, R.E. & Swank, R.T. (2003) Hermansky–Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nature Genetics, 35, 8489.
  • Lichtin, A. (1996) The ITP practice guideline: what, why, and for whom? Blood, 88, 12.
  • Liesner, R., Hann, I. & Khair, K. (2004) Non-accidental injury and the haematologist: the causes and investigation of easy bruising. Blood Coagulation and Fibrinolysis, 15(Suppl. 1), S41S48.
  • Lind, S.E. (1991) The bleeding time does not predict surgical bleeding. Blood, 77, 25472552.
  • Lind, S.E. (2002) The bleeding time. In: Platelets (ed. by A.D.Michelson), pp. 283289. Academic Press, San Diego, CA.
  • Litzman, J., Jones, A., Hann, I., Chapel, H., Strobel, S. & Morgan, G. (1996) Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott–Aldrich syndrome. Archives of Disease in Childhood, 75, 436439.
  • Llewelyn, C.A., Hewitt, P.E., Knight, R.S., Amar, K., Cousens, S., Mackenzie, J. & Will, R.G. (2004) Possible transmission of variant Creutzfeldt–Jakob disease by blood transfusion. Lancet, 363, 417421.
  • Lo, B., Li, L., Gissen, P., Christensen, H., McKiernan, P.J., Ye, C., Abdelhaleem, M., Hayes, J.A., Williams, M.D., Chitayat, D. & Kahr, W.H. (2005) Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet alpha-granule biogenesis. Blood, 106, 41594166.
  • Lopez, J.A., Andrews, R.K., Afshar-Kharghan, V. & Berndt, M.C. (1998) Bernard–Soulier syndrome. Blood, 91, 43974418.
  • Lova, P., Campus, F., Lombardi, R., Cattaneo, M., Sinigaglia, F., Balduini, C. & Torti, M. (2004) Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the G(i)-independent activation of platelet Rap1B by thrombin. Journal of Biological Chemistry, 279, 2529925306.
  • Macheta, M.P., Minford, A.M.B. & Parapia, L.A. (1997) Incidence of hereditary bleeding disorders in Bradford, U.K.: variation with ethnic group. Haemophilia, 3, 292294.
  • Makris, M., Conlon, C.P. & Watson, H.G. (2003) Immunization of patients with bleeding disorders. Haemophilia, 9, 541546.
  • Malmsten, C., Hamberg, M., Svensson, J. & Samuelsson, B. (1975) Physiological role of an endoperoxide in human platelets: hemostatic defect due to platelet cyclo-oxygenase deficiency. Proceedings of the National Academy of Sciences of the United States of America, 72, 14461450.
  • Mannucci, P.M. (1997) Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. Blood, 90, 25152521.
  • Markovitch, O., Ellis, M., Holzinger, M., Goldberger, S. & Beyth, Y. (1998) Severe juvenile vaginal bleeding due to Glanzmann's thrombasthenia: case report and review of the literature. American Journal of Hematology, 57, 225227.
  • McColl, M.D. & Gibson, B.E. (1997) Sibling allogeneic bone marrow transplantation in a patient with type I Glanzmann's thrombasthenia. British Journal of Haematology, 99, 5860.
  • Mehaffey, M.G., Newton, A.L., Gandhi, M.J., Crossley, M. & Drachman, J.G. (2001) X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood, 98, 26812688.
  • Mestel, F., Oetliker, O., Beck, E., Felix, R., Imbach, P. & Wagner, H.P. (1980) Severe bleeding associated with defective thromboxane synthetase. Lancet, 1, 157.
  • Miller, J.L., Lyle, V.A. & Cunningham, D. (1992) Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Ib alpha leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard–Soulier disease. Blood, 79, 439446.
  • Moffat, K.A., Ledford-Kraemer, M.R., Nichols, W.L. & Hayward, C.P. (2005) Variability in clinical laboratory practice in testing for disorders of platelet function: results of two surveys of the North American Specialized Coagulation Laboratory Association. Thrombosis and Haemostasis, 93, 549553.
  • Montgomery, R.R., Kunicki, T.J., Taves, C., Pidard, D. & Corcoran, M. (1983) Diagnosis of Bernard–Soulier syndrome and Glanzmann's thrombasthenia with a monoclonal assay on whole blood. Journal of Clinical Investigation, 71, 385389.
  • Morgan, N.V., Pasha, S., Johnson, C.A., Ainsworth, J.R., Eady, R.A.J., Dawood, B.B., McKeown, C., Trembath, R.C., Wilde, J., Watson, S.P. & Maher, E.R. (2006) A germline mutation in BLOC1S3/redunced pigmentation causes a novel variant of Hermansky–Pudlak syndrome (HPS). American Journal of Human Genetics, 78, 160166.
  • Moroi, M., Jung, S.M., Okuma, M. & Shinmyozu, K. (1989) A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. Journal of Clinical Investigation, 84, 14401445.
  • Mullen, C.A., Anderson, K.D. & Blaese, R.M. (1993) Splenectomy and/or bone marrow transplantation in the management of the Wiskott–Aldrich syndrome: long-term follow-up of 62 cases. Blood, 82, 29612966.
  • Munnix, I.C., Harmsma, M., Giddings, J.C., Collins, P.W., Feijge, M.A., Comfurius, P., Heemskerk, J.W. & Bevers, E.M. (2003) Store-mediated calcium entry in the regulation of phosphatidylserine exposure in blood cells from Scott patients. Thrombosis and Haemostasis, 89, 687695.
  • Muraoka, K., Ishii, E., Ihara, K., Imayoshi, M., Miyazaki, S., Hara, T. & Hamasaki, Y. (2005) Successful bone marrow transplantation in a patient with c-mpl-mutated congenital amegakaryocytic thrombocytopenia from a carrier donor. Pediatric Transplantation, 9, 101103.
  • Murphy, S., Oski, F.A., Naiman, J.L., Lusch, C.J., Goldberg, S. & Gardner, F.H. (1972) Platelet size and kinetics in hereditary and acquired thrombocytopenia. New England Journal of Medicine, 286, 499504.
  • Nakagawa, M., Okuno, M., Okamoto, N., Fujino, H. & Kato, H. (2001) Bernard–Soulier syndrome associated with 22q11.2 microdeletion. American Journal of Medical Genetics, 99, 286288.
  • Nardone, G., Rocco, A., Balzano, T. & Budillon, G. (1999) The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Alimentary Pharmacology and Therapeutics, 13, 14291436.
  • Nichols, K.E., Crispino, J.D., Poncz, M., White, J.G., Orkin, S.H., Maris, J.M. & Weiss, M.J. (2000) Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. Nature Genetics, 24, 266270.
  • Nieuwenhuis, H.K., Akkerman, J.W. & Sixma, J.J. (1987) Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. Blood, 70, 620623.
  • Novotny, V.M. (1999) Prevention and management of platelet transfusion refractoriness. Vox Sanguinis, 76, 113.
  • Nurden, A.T. & Caen, J.P. (1975) Specific roles for platelet surface glycoproteins in platelet function. Nature, 255, 720722.
  • Nurden, P., Savi, P., Heilmann, E., Bihour, C., Herbert, J.M., Maffrand, J.P. & Nurden, A. (1995) An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function. Journal of Clinical Investigation, 95, 16121622.
  • Nurden, P., Jandrot-Perrus, M., Combrie, R., Winckler, J., Arocas, V., Lecut, C., Pasquet, J.M., Kunicki, T.J. & Nurden, A.T. (2004) Severe deficiency of glycoprotein VI in a patient with gray platelet syndrome. Blood, 104, 107114.
  • Ochs, H.D. (1998) The Wiskott–Aldrich syndrome. Seminars in Hematology, 35, 332345.
  • Ochs, H.D., Slichter, S.J., Harker, L.A., Von Behrens, W.E., Clark, R.A. & Wedgwood, R.J. (1980) The Wiskott–Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood, 55, 243252.
  • Oh, J., Bailin, T., Fukai, K., Feng, G.H., Ho, L., Mao, J.I., Frenk, E., Tamura, N. & Spritz, R.A. (1996) Positional cloning of a gene for Hermansky–Pudlak syndrome, a disorder of cytoplasmic organelles. Nature Genetics, 14, 300306.
  • Oh, J., Ho, L., Ala-Mello, S., Amato, D., Armstrong, L., Bellucci, S., Carakushansky, G., Ellis, J.P., Fong, C.T., Green, J.S., Heon, E., Legius, E., Levin, A.V., Nieuwenhuis, H.K., Pinckers, A., Tamura, N., Whiteford, M.L., Yamasaki, H. & Spritz, R.A. (1998) Mutation analysis of patients with Hermansky–Pudlak syndrome: a frameshift hot spot in the HPS gene and apparent locus heterogeneity. American Journal of Human Genetics, 62, 593598.
  • Van Den Oudenrijn, S., Bruin, M., Folman, C.C., Peters, M., Faulkner, L.B., De Haas, M. & Von Dem Borne, A.E. (2000) Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia. British Journal of Haematology, 110, 441448.
  • Pang, L., Weiss, M.J. & Poncz, M. (2005) Megakaryocyte biology and related disorders. Journal of Clinical Investigation, 115, 33323338.
  • Parry, D.H., Giddings, J.C. & Bloom, A.L. (1980) Familial haemostatic defect associated with reduced prothrombin consumption. British Journal of Haematology, 44, 323334.
  • Patel, S.R., Hartwig, J.H. & Italiano, J.E. (2005) The biogenesis of platelets from megakaryocyte proplatelets. Journal of Clinical Investigation, 115, 33483354.
  • Pecci, A., Noris, P., Invernizzi, R., Savoia, A., Seri, M., Ghiggeri, G.M., Sartore, S., Gangarossa, S., Bizzaro, N. & Balduini, C.L. (2002) Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. British Journal of Haematology, 117, 164167.
  • Peterson, P., Hayes, T.E., Arkin, C.F., Bovill, E.G., Fairweather, R.B., Rock, Jr, W.A., Triplett, D.A. & Brandt, J.T. (1998) The preoperative bleeding time test lacks clinical benefit: College of American Pathologists’ and American Society of Clinical Pathologists’ position article. Archives of Surgery, 133, 134139.
  • Phillips, D.R. & Agin, P.P. (1977) Platelet plasma membrane glycoproteins. Evidence for the presence of nonequivalent disulfide bonds using nonreduced-reduced two-dimensional gel electrophoresis. Journal of Biological Chemistry, 252, 21212126.
  • Pinto da Costa, N., Armari-Alla, C., Plantaz, D. & Pagnier, A. (2003) Bernard–Soulier syndrome revealed by major neonatal thrombocytopenia. Archives of Pediatrics, 10, 983985.
  • Piot, B., Sigaud-Fiks, M., Huet, P., Fressinaud, E., Trossaert, M. & Mercier, J. (2002) Management of dental extractions in patients with bleeding disorders. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics, 93, 247250.
  • Poon, M.C. (2001) Use of recombinant factor VIIa in hereditary bleeding disorders. Current Opinion in Hematology, 8, 312318.
  • Poon, M.C. & D'Oiron, R. (2000) Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group. Blood Coagulation and Fibrinolysis, 11(Suppl. 1), S55S68.
  • Poon, M.C., Demers, C., Jobin, F. & Wu, J.W. (1999) Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood, 94, 39513953.
  • Poon, M.C., D'Oiron, R., Von Depka, M., Khair, K., Negrier, C., Karafoulidou, A., Huth-Kuehne, A. & Morfini, M. (2004) Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey. Journal of Thrombosis and Haemostasis, 2, 10961103.
  • Poujol, C., Ramakrishnan, V., DeGuzman, F., Nurden, A.T., Phillips, D.R. & Nurden, P. (2000) Ultrastructural analysis of megakaryocytes in GPV knockout mice. Thrombosis and Haemostasis, 84, 312318.
  • Poujol, C., Ware, J., Nieswandt, B., Nurden, A.T. & Nurden, P. (2002) Absence of GPIbalpha is responsible for aberrant membrane development during megakaryocyte maturation: ultrastructural study using a transgenic model. Experimental Hematology, 30, 352360.
  • Prabu, P. & Parapia, L.A. (2006) Bernard–Soulier syndrome in pregnancy. Clinical and Laboratory Haematology, 28, 198201.
  • Quiroga, T., Pereira, J. & Mezzano, D. (2004) Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients – a reply to rebuttals. Journal of Thrombosis and Haemostasis, 2, 22832285.
  • Raccuglia, G. (1971) Gray platelet syndrome: a variety of qualitative platelet disorders. American Journal of Medicine, 51, 818828.
  • Rajasekhar, D., Kestin, A.S., Bednarek, F.J., Ellis, P.A., Barnard, M.R. & Michelson, A.D. (1994) Neonatal platelets are less reactive than adult platelets to physiological agonists in whole blood. Thrombosis and Haemostasis, 72, 957963.
  • Rajasekhar, D., Barnard, M.R., Bednarak, F.J. & Michelson, A.D. (1997) Platelet hyporeactivity in very low birth weight neonates. Thrombosis and Haemostasis, 77, 10021007.
  • Ramasamy, I. (2004) Inherited bleeding disorders: disorders of platelet adhesion and aggregation. Critical Reviews in Oncology/Hematology, 49, 135.
  • Rao, A.K. (2002) Acquired disorders of platelet function. In: Platelets (ed. by A.D.Michelson), pp. 701726. Academic Press, San Diego, CA.
  • Rao, A.K., Koike, K., Day, H.J., Smith, J.B. & Holmsen, H. (1985) Bleeding disorder associated with albumin-dependent partial deficiency in platelet thromboxane production. Effect of albumin on arachidonate metabolism in platelets. American Journal of Clinical Pathology, 83, 687696.
  • Rao, A.K., Willis, J., Kowalska, M.A., Wachtfogel, Y.T. & Colman, R.W. (1988) Differential requirements for platelet aggregation and inhibition of adenylate cyclase by epinephrine. Studies of a familial platelet alpha 2-adrenergic receptor defect. Blood, 71, 494501.
  • Rao, A.K., Ghosh, S., Sun, L., Yang, X., Disa, J., Pickens, P. & Polansky, M. (1995) Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial. Thrombosis and Haemostasis, 74, 10711078.
  • Rao, A.K., Jalagadugula, G. & Sun, L. (2004) Inherited defects in platelet signaling mechanisms. Semininars in Thrombosis and Hemostasis, 30, 525535.
  • Raslova, H., Komura, E., Le Couedic, J.P., Larbret, F., Debili, N., Feunteun, J., Danos, O., Albagli, O., Vainchenker, W. & Favier, R. (2004) FLI1 monoallelic expression combined with its hemizygous loss underlies Paris–Trousseau/Jacobsen thrombopenia. Journal of Clinical Investigation, 114, 7784.
  • Reichert, N., Seligsohn, U. & Ramot, B. (1975) Clinical and genetic aspects of Glanzmann's thrombasthenia in Israel: report of 22 cases. Thrombosis et Diathesis Haemorrhagica, 34, 806820.
  • Remold-O'Donnell, E., Rosen, F.S. & Kenney, D.M. (1996) Defects in Wiskott–Aldrich syndrome blood cells. Blood, 87, 26212631.
  • Rodgers, R.P. & Levin, J. (1990) A critical reappraisal of the bleeding time. Seminars in Thrombosis and Hemostasis, 16, 120.
  • Ryo, R., Yoshida, A., Sugano, W., Yasunaga, M., Nakayama, K., Saigo, K., Adachi, M., Yamaguchi, N. & Okuma, M. (1992) Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen-induced platelet aggregation. American Journal of Hematology, 39, 2531.
  • Samama, M., Lecrubier, C., Conard, J., Hotchen, M., Breton-Gorius, J., Vargaftig, B., Chignard, M., Lagarde, M. & Dechavanne, M. (1981) Constitutional thrombocytopathy with subnormal response to thromboxane A2. British Journal of Haematology, 48, 293303.
  • Savoia, A., Balduini, C.L., Savino, M., Noris, P., Del Vecchio, M., Perrotta, S., Belletti, S., Poggi, V. & Iolascon, A. (2001) Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard–Soulier syndrome. Blood, 97, 13301335.
  • Schulman, S., Johnsson, H., Egberg, N. & Blomback, M. (1987) DDAVP-induced correction of prolonged bleeding time in patients with congenital platelet function defects. Thrombosis Research, 45, 165174.
  • Seghatchian, J. (2003) Universal leucodepletion: an overview of some unresolved issues and the highlights of lessons learned. Transfusion and Apheresis Science, 29, 105117.
  • Seligsohn, U. & Rososhansky, S. (1984) A Glanzmann's thrombasthenia cluster among Iraqi Jews in Israel. Thrombosis and Haemostasis, 52, 230231.
  • Seri, M., Cusano, R., Gangarossa, S., Caridi, G., Bordo, D., Lo Nigro, C., Ghiggeri, G.M., Ravazzolo, R., Savino, M., Del Vecchio, M., Apolito, M., Iolascon, A., Zelante, L.L., Savoia, A., Balduini, C.L., Noris, P., Magrini, U., Belletti, S., Heath, K.E., Babcock, M., Glucksman, M.J., D'Aliprandis, E., Bizzaro, N., Desnick, R.J. & Martignetti, J.A. (2000) Mutations in MYH9 result in the May–Hegglin anomaly, and Fechtner and Sebastian syndromes. The May–Heggllin/Fechtner Syndrome Consortium. Nature Genetics, 26, 103105.
  • Seri, M., Pecci, A., Di Bari, F., Cusano, R., Savino, M., Panza, E., Nigro, A., Noris, P., Gangarossa, S., Rocca, B., Gresele, P., Bizzaro, N., Malatesta, P., Koivisto, P.A., Longo, I., Musso, R., Pecoraro, C., Iolascon, A., Magrini, U., Rodriguez Soriano, J., Renieri, A., Ghiggeri, G.M., Ravazzolo, R., Balduini, C.L. & Savoia, A. (2003) MYH9-related disease: May–Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine, 82, 203215.
  • Shapiro, A.D. (2000) Platelet function disorders. Haemophilia, 6(Suppl. 1), 120127.
  • Sheth, P.M., Kahr, W.H., Haq, M.A., Veljkovic, D.K., Rivard, G.E. & Hayward, C.P. (2003) Intracellular activation of the fibrinolytic cascade in the Quebec platelet disorder. Thrombosis and Haemostasis, 90, 293298.
  • Shivdasani, R.A. (2001) Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells, 19, 397407.
  • Sims, P.J., Wiedmer, T., Esmon, C.T., Weiss, H.J. & Shattil, S.J. (1989) Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. Journal of Biological Chemistry, 264, 1704917057.
  • Sosnoski, D.M., Emanuel, B.S., Hawkins, A.L., Van Tuinen, P., Ledbetter, D.H., Nussbaum, R.L., Kaos, F.T., Schwartz, E., Phillips, D., Bennett, J.S., Fitzgerald, L.A. & Poncz, M. (1988) Chromosomal localization of the genes for the vitronectin and fibronectin receptors alpha subunits and for platelet glycoproteins IIb and IIIa. Journal of Clinical Investigation, 81, 19931998.
  • Spritz, R.A., Chiang, P.W., Oiso, N. & Alkhateeb, A. (2003) Human and mouse disorders of pigmentation. Current Opinion in Genetic Development, 13, 284289.
  • Starcevic, M. & Dell'Angelica, E.C. (2004) Identification of snapin and three novel proteins (BLOS1, BLOS2, and BLOS3/reduced pigmentation) as subunits of biogenesis of lysosome-related organelles complex-1 (BLOC-1). Journal of Biological Chemistry, 279, 2839328401.
  • Steele, M., Hitzler, J., Doyle, J.J., Germeshausen, M., Fernandez, C.V., Yuille, K. & Dror, Y. (2005) Reduced intensity hematopoietic stem-cell transplantation across human leukocyte antigen barriers in a patient with congenital amegakaryocytic thrombocytopenia and monosomy 7. Pediatric Blood and Cancer, 45, 212216.
  • Stormorken, H. (2002) Stormorken's syndrome. Tidsskrift for den Norske Laegeforen, 122, 28532856.
  • Stormorken, H., Sjaastad, O., Langslet, A., Sulg, I., Egge, K. & Diderichsen, J. (1985) A new syndrome: thrombocytopathia, muscle fatigue, asplenia, miosis, migraine, dyslexia and ichthyosis. Clinical Genetics, 28, 367374.
  • Stormorken, H., Holmsen, H., Sund, R., Sakariassen, K.S., Hovig, T., Jellum, E. & Solum, O. (1995) Studies on the haemostatic defect in a complicated syndrome. An inverse Scott syndrome platelet membrane abnormality? Thrombosis and Haemostasis, 74, 12441251.
  • Sullivan, K.E., Mullen, C.A., Blaese, R.M. & Winkelstein, J.A. (1994) A multiinstitutional survey of the Wiskott–Aldrich syndrome. Journal of Pediatrics, 125, 876885.
  • Summerfield, G.P., Keenan, J.P., Brodie, N.J. & Bellingham, A.J. (1981) Bioluminescent assay of adenine nucleotides: rapid analysis of ATP and ADP in red cells and platelets using the LKB luminometer. Clinical and Laboratory Haematology, 3, 257271.
  • Swank, R.T., Jiang, S.Y., Reddington, M., Conway, J., Stephenson, D., McGarry, M.P. & Novak, E.K. (1993) Inherited abnormalities in platelet organelles and platelet formation and associated altered expression of low molecular weight guanosine triphosphate-binding proteins in the mouse pigment mutant gunmetal. Blood, 81, 26262635.
  • Tamponi, G., Pannocchia, A., Arduino, C., Bazzan, M., Della Dora, N., Schinco, P., Buraglio, M. & Eandi, M. (1987) Congenital deficiency of alpha-2-adrenoceptors on human platelets: description of two cases. Thrombosis and Haemostasis, 58, 10121016.
  • Tengborn, L. & Petruson, B. (1996) A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa. Thrombosis and Haemostasis, 75, 981982.
  • Thompson, A.A. & Nguyen, L.T. (2000) Amegakaryocytic thrombocytopenia and radio-ulnar synostosis are associated with HOXA11 mutation. Nature Genetics, 26, 397398.
  • Thompson, A.R., Wood, W.G. & Stamatoyannopoulos, G. (1977) X-linked syndrome of platelet dysfunction, thrombocytopenia, and imbalanced globin chain synthesis with hemolysis. Blood, 50, 303316.
  • Thompson, A.A., Woodruff, K., Feig, S.A., Nguyen, L.T. & Schanen, N.C. (2001) Congenital thrombocytopenia and radio-ulnar synostosis: a new familial syndrome. British Journal of Haematology, 113, 866870.
  • Tyagi, A. & Bhattacharya, A. (2002) Central neuraxial blocks and anticoagulation: a review of current trends. European Journal of Anaesthesiology, 19, 317329.
  • Van Geet, C., Devriendt, K., Eyskens, B., Vermylen, J. & Hoylaerts, M.F. (1998) Velocardiofacial syndrome patients with a heterozygous chromosome 22q11 deletion have giant platelets. Pediatric Research, 44, 607611.
  • Villar, A., Aronis, S., Morfini, M., Santagostino, E., Auerswald, G., Thomsen, H.F., Erhardtsen, E. & Giangrande, P.L. (2004) Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children versus adults with haemophilia A. Haemophilia, 10, 352359.
  • Vivier, M., Treisser, A., Naett, M., Diemunsch, P., Schmitt, J.P., Waller, C., Tongio, M.M., Hemmendinger, S. & Lutz, P. (1989) Glanzmann's thrombasthenia and pregnancy. Contribution of plasma exchange before scheduled cesarean section. Journal de Gynecologie Obstetrique et Biologie de la Reproduction (Paris), 18, 507513.
  • Wall, J.E., Buijs-Wilts, M., Arnold, J.T., Wang, W., White, M.M., Jennings, L.K. & Jackson, C.W. (1995) A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents. British Journal of Haematology, 89, 380385.
  • Weiss, H.J. & Lages, B. (1988) The response of platelets to epinephrine in storage pool deficiency – evidence pertaining to the role of adenosine diphosphate in mediating primary and secondary aggregation. Blood, 72, 17171725.
  • Weiss, H.J. & Lages, B. (1997) Family studies in Scott syndrome. Blood, 90, 475476.
  • Weiss, H.J., Vicic, W.J., Lages, B.A. & Rogers, J. (1979) Isolated deficiency of platelet procoagulant activity. American Journal of Medicine, 67, 206213.
  • Weiss, H.J., Turitto, V.T. & Baumgartner, H.R. (1986) Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood, 67, 322330.
  • Weiss, H.J., Lages, B., Vicic, W., Tsung, L.Y. & White, J.G. (1993) Heterogeneous abnormalities of platelet dense granule ultrastructure in 20 patients with congenital storage pool deficiency. British Journal of Haematology, 83, 282295.
  • Weiss, H.J., Lages, B., Zheng, S. & Hayward, C.P. (2001) Platelet factor V New York: a defect in factor V distinct from that in factor V Quebec resulting in impaired prothrombinase generation. American Journal of Hematology, 66, 130139.
  • White, D.G. (1969) The dense bodies of human platelets: inherent electron opacity of serotonin storage organelles. Blood, 33, 598606.
  • Wiskott, A. (1937) Familiarer, angeborener Morbus Werlhofii? Monatsschrift Kinderheilkunde, 68, 212216.
  • Witkop, C.J., Nunez Babcock, M., Rao, G.H., Gaudier, F., Summers, C.G., Shanahan, F., Harmon, K.R., Townsend, D., Sedano, H.O. & King, R.A. (1990) Albinism and Hermansky–Pudlak syndrome in Puerto Rico. Bulletin of the Medical Association of Puerto Rico, 82, 333339.
  • Wu, K.K., Le Breton, G.C., Tai, H.H. & Chen, Y.C. (1981) Abnormal platelet response to thromboxane A2. Journal of Clinical Investigation, 67, 18011804.
  • Wun, T., Paglieroni, T.G. & Lachant, N.A. (1995) Desmopressin stimulates the expression of P-selectin on human platelets in vitro. Journal of Laboratory and Clinical Medicine, 126, 401409.
  • Yesilipek, M.A., Hazar, V., Kupesiz, A. & Yegin, O. (2000) Peripheral stem cell transplantation in a child with amegakaryocytic thrombocytopenia. Bone Marrow Transplantation, 26, 571572.
  • Yu, C., Niakan, K.K., Matsushita, M., Stamatoyannopoulos, G., Orkin, S.H. & Raskind, W.H. (2002) X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. Blood, 100, 20402045.
  • Zhou, L. & Schmaier, A.H. (2005) Platelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field. American Journal of Clinical Pathology, 123, 172183.
  • Zhu, Q., Zhang, M., Blaese, R.M., Derry, J.M., Junker, A., Francke, U., Chen, S.H. & Ochs, H.D. (1995) The Wiskott–Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. Blood, 86, 37973804.